Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigation of Dysregulated Signaling in Myeloproliferative Disorders Via Multiparameter Phospho-specific Flow Cytometry

NCT01144780 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT01144780
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01144780 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigation of Dysregulated Signaling in Myeloproliferative Disorders Via Multiparameter Phospho-specific Flow Cytometry
Lead sponsor
Stanford University
Phase
Observational
Overall status
Terminated
Start date
September 30, 2009
Completion date
June 30, 2012
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

myeloproliferative disorders, myeloproliferative disorders (mpd)